Samsara BioCapital’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-80,963
| Closed | -$4.2M | – | 43 |
|
|
2023
Q3 | $4.2M | Hold |
80,963
| – | – | 1.29% | 22 |
|
|
2023
Q2 | $4.85M | Hold |
80,963
| – | – | 0.85% | 21 |
|
|
2023
Q1 | $4M | Hold |
80,963
| – | – | 0.83% | 23 |
|
|
2022
Q4 | $4.62M | Hold |
80,963
| – | – | 0.99% | 22 |
|
|
2022
Q3 | $3.8M | Sell |
80,963
-80,000
| -50% | -$3.75M | 0.89% | 25 |
|
|
2022
Q2 | $6.01M | Hold |
160,963
| – | – | 1.6% | 17 |
|
|
2022
Q1 | $4.81M | Buy |
160,963
+96,963
| +152% | +$2.9M | 1.21% | 20 |
|
|
2021
Q4 | $2.19M | Hold |
64,000
| – | – | 0.43% | 34 |
|
|
2021
Q3 | $2.37M | Hold |
64,000
| – | – | 0.37% | 35 |
|
|
2021
Q2 | $2.5M | Sell |
64,000
-16,000
| -20% | -$625K | 0.31% | 37 |
|
|
2021
Q1 | $3.41M | Buy |
+80,000
| New | +$3.41M | 0.63% | 32 |
|